INmune Bio
INMB
INMB
41 hedge funds and large institutions have $30.6M invested in INmune Bio in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.9% more ownership
Funds ownership: 8.75% → 11.65% (+2.9%)
7% more call options, than puts
Call options by funds: $1.04M | Put options by funds: $972K
Holders
41
Holding in Top 10
–
Calls
$1.04M
Puts
$972K
Top Buyers
| 1 | +$2.84M | |
| 2 | +$2.05M | |
| 3 | +$1.16M | |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$1.01M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$985K |
Top Sellers
| 1 | -$1.52M | |
| 2 | -$628K | |
| 3 | -$536K | |
| 4 |
Millennium Management
New York
|
-$499K |
| 5 |
HF
HRT Financial
New York
|
-$262K |